The role of luteal phase nidatory estrogen secreted shortly before implantation in induction of endometrial receptivity to the stimulus of blastocyst for decidual transformation in laboratory rodents that exhibit facul¬ tative delayed implantation is well established (1 ) . While there is a paucity of documentary proof regarding the role of estrogen in decidualization and implantation in any primate species, a prenidatory rise in plasma estradiol is known to occur in women and marmosets ( 1, 2) . This is presumed to indicate an estrogen requirement for implantation in these species. In rhesus monkeys no such alteration in peripheral estrogen levels during the prenidatory phase is evident, but a shift in the ratio of progesterone to estradiol concentration in endometrium depicting an apparent estrogenism and increased occu¬ pancy of nuclear estrogen and progesterone receptors has been observed during fertile cycles (3) . Centchroman ( Fig. 1 ) is a potent non-steroidal anties¬ trogen reported to provide good pregnancy protection in women in post-coital as well as weekly regimens (4) . It also provides partial to complete remission in some breast cancer patients (5) and has recently been licensed for marketing in India.
The anti-implantation action of centchroman involves the inhibition of uterine decidualization and implantation associated biochemical markers (6) , with¬ out affecting the pre-implantation development of embryos up to the blastocyst stage (7) . While (90) 8 (100) 6 (75) 6 (75) 3 (100) 6 (100) 3 (100) 7 (100) 7 (78) (99) 74 (79) 70 (84) 34 (65) 33 (52) 32 (100) 67 (100) 35 (100) - (0) All other relevant comparisons were statistically insignificant. (21) . The findings of Psychoyos (20) 
